{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06289582",
            "orgStudyIdInfo": {
                "id": "R24-004"
            },
            "organization": {
                "fullName": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "briefTitle": "Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)",
            "officialTitle": "Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)",
            "therapeuticArea": [
                "Neurology"
            ],
            "study": "longitudinal-tspo-pet-imaging-with-dpa-in-ppmi-ppmi-dpa-pet-imaging"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-13",
            "studyFirstSubmitQcDate": "2024-02-28",
            "studyFirstPostDateStruct": {
                "date": "2024-03-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jonathan E McConathy",
                "investigatorTitle": "M.D. P.h.D., Director for the Division Molecular Imaging and Therapeutics",
                "investigatorAffiliation": "University of Alabama at Birmingham"
            },
            "leadSponsor": {
                "name": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Michael J. Fox Foundation for Parkinson's Research",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The overall goal of this protocol is to investigate \\[18F\\]DPA-714 binding in prodromal and early manifest Parkinson's Disease (PD) and to determine the baseline and change from baseline in \\[18F\\]DPA-714 binding in PD participants during a 24-month interval.\n\nPrimary Objectives\n\n* To compare \\[18F\\]DPA-714 binding in prodromal and manifest PD and healthy volunteers.\n* To determine the longitudinal change in \\[18F\\]DPA-714 during a 24-month interval for prodromal and early initially untreated PD participants.\n\nSecondary Objectives\n\n* To evaluate the correlation between baseline \\[18F\\]DPA-714 and PPMI clinical and biomarker outcomes.\n* To evaluate the correlation between the longitudinal change of \\[18F\\]DPA-714 and PPMI clinical and biomarker outcomes\n* To acquire safety data following injection of \\[18F\\]DPA-714"
        },
        "conditionsModule": {
            "conditions": [
                "Parkinson Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Prodromal and manifest (PD) participants",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: [F-18]DPA714 administration IV"
                    ]
                },
                {
                    "label": "Healthy participants",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: [F-18]DPA714 administration IV"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "[F-18]DPA714 administration IV",
                    "description": "brain PET/MRI imaging after \\[F-18\\]DPA-714 administration",
                    "armGroupLabels": [
                        "Healthy participants",
                        "Prodromal and manifest (PD) participants"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Measure baseline and follow up regional brain TSPO levels using [18F]DPA-714-PET in prodromal PD.",
                    "description": "The changes over time in neuroinflammation based on TSPO will be assessed by comparing TSPO-PET imaging at baseline, 12 months and 24 months after enrollment.",
                    "timeFrame": "24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* A prodromal PD and Healthy participant enrolled in PPMI Clinical protocol\n* A PD participant enrolled in PPMI Clinical protocol who has not started symptomatic treatment at time of enrollment or in the first 2 years of participation.\n* Able to provide informed consent\n* Must have screening genetic testing documenting high binder at the at the known TSPO gene polymorphism (rs6971)\n* Male or Female (Females must meet additional criteria specified below, as applicable)\n\n  \u2022 Females must be of non-childbearing potential or using a highly effective method of birth control 14 days prior to until at least 24 hours after injection of \\[18F\\]DPA-714\n* Non-childbearing potential is defined as a female that must be either postmenopausal (no menses for at least 12 months prior to PET scan) or surgically sterile (bilateral tubal ligation, bilateral oophorectomy or hysterectomy).\n* Highly effective method of birth control is defined as practicing at least one of the following: A birth control method that results in a less than 1% per year failure rate when used consistently and correctly, such as oral contraceptives for at least 3 months prior to injection, an intrauterine device (IUD) for at least 2 months prior to injection, or barrier methods, e.g., diaphragm or combination condom and spermicide. Periodic abstinence (e.g., calendar, ovulation, symptothermal, post-ovulation methods) is not acceptable.\n\n  * Females of childbearing potential must not be pregnant, breastfeeding or lactating.\n  * Includes a negative urine pregnancy test prior to injection of \\[18F\\]DPA-714 on day of PET scan.\n\nExclusion Criteria:\n\n* Exposure to a total effective dose equivalent of 50 millisievert (mSv) for the whole body, which is the annual limit established by the US Code of Federal Regulations , during the past year.\n* Any other medical or psychiatric condition or lab abnormality, which in the opinion of the Site Investigator might preclude participation.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Evan Hudson",
                    "role": "CONTACT",
                    "phone": "205-934-6499",
                    "email": "evanhusdon@uabmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jonathan McConathy, MD, PhD",
                    "affiliation": "University of Alabama at Birmingham",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "David Standaert, MD, PhD",
                    "affiliation": "University of Alabama at Birmingham",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "UAB",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35294",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Evan Hudson, BS",
                            "role": "CONTACT",
                            "phone": "205-934-6499",
                            "email": "evanhudson@uabmc.edu"
                        },
                        {
                            "name": "Jonathan McConathy, MD,PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010300",
                    "term": "Parkinson Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020734",
                    "term": "Parkinsonian Disorders"
                },
                {
                    "id": "D000001480",
                    "term": "Basal Ganglia Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009069",
                    "term": "Movement Disorders"
                },
                {
                    "id": "D000080874",
                    "term": "Synucleinopathies"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13213",
                    "name": "Parkinson Disease",
                    "asFound": "Parkinson's Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22494",
                    "name": "Parkinsonian Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M25603",
                    "name": "Ganglion Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M16358",
                    "name": "Synovial Cyst",
                    "relevance": "LOW"
                },
                {
                    "id": "M4774",
                    "name": "Basal Ganglia Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12029",
                    "name": "Movement Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M2217",
                    "name": "Synucleinopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                }
            ]
        }
    },
    "hasResults": false
}